QLY BIOTECH GROUP CORP. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0d00e64e-3c2d-4d8f-bc12-667cb5667fe0/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $0 | 2021-09-01 – 2022-08-31 | evidence 0001477932-22-009289 |
| FY 2021 | $4.0k | 2020-09-01 – 2021-08-31 | evidence 0001477932-21-008726 |
| FY 2020 | $4.0k | 2019-09-01 – 2020-08-31 | evidence 0001477932-20-005756 |
| FY 2019 | $0 | 2018-09-20 – 2019-08-31 | evidence 0001477932-20-005756 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
QLY BIOTECH GROUP CORP. — all facts · Net Income · Operating Income